Elixirgen Therapeutics’ Innovative Approach to mRNA Therapeutics
XTalks
JUNE 18, 2024
In a field quickly gaining attention for its role in vaccine development and personalized medicine, Elixirgen Therapeutics stands out through its pursuit of innovation and safety. EXG-34217 is an autologous cell therapy, meaning it uses the patient’s own cells, modified to express ZSCAN4 and thereby extend their telomeres.
Let's personalize your content